Even though the fact that cervical cancer can be prohibited, approximately 60,000 women gets affected by the disease annually. Human papillomavirus (HPV) virus is the main cause of cervical cancer. Thanks to government screening program organized by most of European countries, deaths from cervical cancer has decreased over the past 30 years. Throughout this phase mortality rate has decreased; but still in present times one woman dies per 25,000 in European region. Our Report title “Europe Cervical Cancer Test Market, Patients, By Screening Type (Pap Smear, HPV DNA) (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway, Netherlands)” provides details of the following points:
Germany is the Leader in European Cervical Cancer Testing Population
On the basis of general population, Germany is 2nd largest country in European region. It has good healthcare infrastructure. Germany offers widespread access to health care for the whole population, irrespective of income, insurance status, gender, age and social status. As for cancer care the quality standards are high. Generally, cervical cancer treatment and cervical cancer screening is strongly recommended by doctors and policy makers. Cervical cancer screening has been introduced more than 40 years ago; as a result cervical cancer incidence decreased by 70 %. These enhancements are primarily due to usual cervical screening.
Pap Smear Test is Primary Test Method to Examine the Cervical Cancer in Europe
Pap smear test is most popular test method to know the cervical cancer among the European women. Pap test is also called as Papanicolaou test. It can be done in a few minutes by your doctor, nurse, community health in a clinic or consulting room. France, United Kingdom and Germany are most significant countries in the European region cervical cancer Pap smear test market. Europe accounts for a significant market share in global cervical cancer market.
Key Factors of which Cervical Cancer Test Become Popular in Europe
Healthcare infrastructure, per capita healthcare expenditure and government initiatives play a major role for cervical cancer test market across all European countries. Growing awareness about the importance of cervical cancer test among the women, healthcare companies and non-profit organizations (NGOs) initiatives are some other driving factors for this market.
Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.
Follow us on LinkedIn: http://www.linkedin.com/company/renub-research